Badge04,
This is the contact information for Dr. Lalezari and Quest. I believe they review pathology studies for over expressed CCR5 and trial inclusion.
Good luck to you and your friend.
Quest Clinical Research
New Patient Coordinators:
Jamie Streit at (415) 353-0800
Emily Jennings at (415) 353-0800
Patient referrals directly to:
Jacob P. Lalezari, M.D.
Main telephone: (415) 353-0800
2300 Sutter Street, Suite 208
San Francisco, CA 94115
Northwest biopharmaceuticals has a late stage (locked phase 3 trial data waiting readout) glioblastoma treatment. I don’t know if their therapy is available compassionate use, but worth investigating as well.